Fulgent Genetics ROE 2015-2025 | FLGT

Current and historical return on equity (ROE) values for Fulgent Genetics (FLGT) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Fulgent Genetics ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $-0.04B $1.12B -3.72%
2024-12-31 $-0.04B $1.13B -3.81%
2024-09-30 $-0.17B $1.14B -14.59%
2024-06-30 $-0.16B $1.13B -14.02%
2024-03-31 $-0.17B $1.13B -13.79%
2023-12-31 $-0.17B $1.13B -13.56%
2023-09-30 $-0.06B $1.26B -4.98%
2023-06-30 $-0.05B $1.26B -3.78%
2023-03-31 $-0.03B $1.27B -1.95%
2022-12-31 $0.14B $1.27B 11.13%
2022-09-30 $0.27B $1.28B 21.46%
2022-06-30 $0.39B $1.31B 32.52%
2022-03-31 $0.46B $1.31B 41.49%
2021-12-31 $0.51B $1.17B 51.67%
2021-09-30 $0.57B $1.04B 68.35%
2021-06-30 $0.49B $0.92B 79.71%
2021-03-31 $0.42B $0.80B 101.40%
2020-12-31 $0.21B $0.57B 92.64%
2020-09-30 $0.05B $0.19B 43.84%
2020-06-30 $0.00B $0.09B 2.61%
2020-03-31 $0.00B $0.08B -1.48%
2019-12-31 $0.00B $0.08B -1.67%
2019-09-30 $0.00B $0.06B -5.80%
2019-06-30 $-0.01B $0.05B -9.76%
2019-03-31 $-0.01B $0.05B -11.59%
2018-12-31 $-0.01B $0.05B -11.43%
2018-09-30 $-0.01B $0.05B -11.27%
2018-06-30 $-0.01B $0.05B -11.16%
2018-03-31 $-0.01B $0.05B -9.17%
2017-12-31 $0.00B $0.05B -5.45%
2017-09-30 $0.00B $0.06B 0.00%
2017-06-30 $0.00B $0.06B 0.00%
2017-03-31 $-0.01B $0.06B -13.51%
2016-12-31 $-0.01B $0.05B -25.81%
2016-06-30 $-0.01B $0.02B -109.09%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.634B $0.283B
Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $47.172B 60.28
Hims & Hers Health (HIMS) United States $11.812B 122.72
Tempus AI (TEM) United States $10.155B 0.00
IRhythm Technologies (IRTC) United States $4.637B 0.00
Inspire Medical Systems (INSP) United States $4.007B 62.61
Hinge Health (HNGE) United States $3.004B 0.00
Privia Health (PRVA) United States $2.780B 190.00
Enovis (ENOV) United States $1.805B 10.06
Schrodinger (SDGR) United States $1.749B 0.00
Clover Health Investments (CLOV) United States $1.537B 0.00
Phreesia (PHR) United States $1.534B 0.00
Omnicell (OMCL) United States $1.446B 25.51
Azenta (AZTA) United States $1.296B 60.21
10x Genomics (TXG) United States $1.122B 0.00
Claritev (CTEV) United States $0.631B 0.00
Butterfly Network (BFLY) United States $0.581B 0.00
Talkspace (TALK) United States $0.544B 162.50
Veradigm (MDRX) United States $0.487B 0.00
Standard BioTools (LAB) United States $0.378B 0.00
Outset Medical (OM) United States $0.356B 0.00
TruBridge (TBRG) United States $0.353B 784.00
Health Catalyst (HCAT) United States $0.267B 0.00
Nyxoah SA (NYXH) Belgium $0.263B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.135B 0.00
EUDA Health Holdings (EUDA) Singapore $0.124B 0.00
Pulmonx (LUNG) United States $0.120B 0.00
American Well (AMWL) United States $0.108B 0.00
MDxHealth SA (MDXH) Belgium $0.098B 0.00
CareCloud (CCLD) United States $0.091B 3.48
111 (YI) China $0.072B 0.00
HeartBeam (BEAT) United States $0.055B 0.00
P3 Health Partners (PIII) United States $0.047B 0.00
Zepp Health (ZEPP) Netherlands $0.036B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.032B 0.00
Zhongchao (ZCMD) China $0.027B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.015B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00